Vertex announces expansion of reimbursement agreement with nhs england to include kaftrio® in combination with kalydeco®

Vertex announces expansion of reimbursement agreement with nhs england to include kaftrio® (ivacaftor/tezacaftor/elexacaftor) in combination with kalydeco® (ivacaftor).vertex pharmaceuticals inc - has expanded its reimbursement agreement with nhs england for vertex's cystic fibrosis medicines.vertex pharmaceuticals - new agreement includes reimbursed access to vertex's currently licensed medicines - kalydeco, orkambi and symkevi.
VRTX Ratings Summary
VRTX Quant Ranking